The international conference Redefining Early Stage Investments (RESI),, organized by Life Science Nation (LSN), will take place in Barcelona from June 17th to 19th, 2024, to connect early-stage startups with investors to establish strategic alliances. Biocat had organised the Round Table "Catalonia Advanced Therapies Ecosystem: Building Europe’s Future in ATMPs".

Moderator:
Robert Fabregat, CEO Biocat.

Speakers:
Fina Lladós Vice President General Manager lberia Amgen
Silvia Martín-Lluesma Clinical Senior Manager of Advanced Therapies at Vall d’Hebron Institute of Oncology (VHIO)
Antoni Matilla. Cofounder and Director Biointaxis.
Lluís Pareras. Founder and Managing Partner Invivo Ventures
Esteve Trias. Executive Medical Director Leitat Technological Center.

More information: https://www.biocat.cat/en/current-new...

#RESIEurope2024 #Biocat #investment